doi: 10.1016/0378-1097(92)90516-q.
A method of enhancing verocytotoxin production by Escherichia coli
Affiliations
- PMID: 1505736
- DOI: 10.1016/0378-1097(92)90516-q
Item in Clipboard
A method of enhancing verocytotoxin production by Escherichia coli
FEMS Microbiol Lett.
.
Abstract
The number of verocytotoxin producing Escherichia coli (VTEC) present in the faeces during an infection may be very low, making their detection difficult. We report a method for enhancing toxin production by VTEC using mitomycin C as an inducing agent with the aim of improving the detection of VTEC. In pure culture, mitomycin C enhanced toxin production up to 100-fold. When applied to mixed faecal culture, toxin could be detected in mitomycin C treated samples when standard cultures were negative and when substantially fewer verocytotoxin-producing bacteria were present. Use of this method may aid in the detection of VTEC and is appropriate for use in the routine diagnostic laboratory.
Similar articles
-
Detection by ELISA of low numbers of Shiga-like toxin-producing Escherichia coli in mixed cultures after growth in the presence of mitomycin C.J Med Microbiol. 1992 Mar;36(3):198-202. doi: 10.1099/00222615-36-3-198. J Med Microbiol. 1992. PMID: 1548693
-
[Prevalence and serotypes of verocytotoxin-producing Escherichia coli (VTEC) isolates from dairy cattle].Kansenshogaku Zasshi. 1999 May;73(5):445-50. doi: 10.11150/kansenshogakuzasshi1970.73.445. Kansenshogaku Zasshi. 1999. PMID: 10386024 Japanese.
-
A comparison of immunomagnetic separation, direct culture and polymerase chain reaction for the detection of verocytotoxin-producing Escherichia coli O157 in human faeces.J Med Microbiol. 1996 Mar;44(3):219-22. doi: 10.1099/00222615-44-3-219. J Med Microbiol. 1996. PMID: 8636941
-
[Infections with verocytotoxin-producing Escherichia coli and hemolytic-uremic syndrome].Ned Tijdschr Geneeskd. 1996 Jan 20;140(3):134-7. Ned Tijdschr Geneeskd. 1996. PMID: 8618631 Review. Dutch.
-
[Hemorrhagic colitis and hemolytic-uremic syndrome--E. coli as etiological agent. II. Clinical aspects and epidemiology].Kinderarztl Prax. 1991 Jul-Aug;59(7-8):200-5. Kinderarztl Prax. 1991. PMID: 1921170 Review. German.
Cited by
-
Shiga toxin-producing Escherichia coli-associated kidney failure in a 40-year-old patient and late diagnosis by novel bacteriologic and toxin detection methods.J Clin Microbiol. 2003 Jul;41(7):3438-40. doi: 10.1128/JCM.41.7.3438-3440.2003. J Clin Microbiol. 2003. PMID: 12843115 Free PMC article.
-
Regulation of the Shiga-like toxin II operon in Escherichia coli.Infect Immun. 1996 Feb;64(2):495-502. doi: 10.1128/iai.64.2.495-502.1996. Infect Immun. 1996. PMID: 8550198 Free PMC article.
-
Comparison of Shiga toxin production by hemolytic-uremic syndrome-associated and bovine-associated Shiga toxin-producing Escherichia coli isolates.Appl Environ Microbiol. 2003 Feb;69(2):1059-66. doi: 10.1128/AEM.69.2.1059-1066.2003. Appl Environ Microbiol. 2003. PMID: 12571029 Free PMC article.
-
The N-terminal domain of EspF induces host cell apoptosis after infection with enterohaemorrhagic Escherichia coli O157:H7.PLoS One. 2013;8(1):e55164. doi: 10.1371/journal.pone.0055164. Epub 2013 Jan 25. PLoS One. 2013. PMID: 23372831 Free PMC article.
-
The EspF N-Terminal of Enterohemorrhagic Escherichia coli O157:H7 EDL933w Imparts Stronger Toxicity Effects on HT-29 Cells than the C-Terminal.Front Cell Infect Microbiol. 2017 Sep 21;7:410. doi: 10.3389/fcimb.2017.00410. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28983470 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
